EDGAR Filing Documents for 0001193805-06-000788

Form SC 13G - Statement of acquisition of beneficial ownership by individuals:

SEC Accession No. 0001193805-06-000788

Filing Date

2006-03-28

Accepted

2006-03-27 19:41:56

Documents

Group Members

DEERFIELD CAPITAL, L.P.DEERFIELD INTERNATIONAL LIMITEDDEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITEDDEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq	Description	Document	Type	Size
1	SCHEDULE 13G	e600336_sc13g-sunesis.txt	SC 13G	33060
	Complete submission text file	0001193805-06-000788.txt		35286

Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080

Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500

SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878
Type: SC 13G | Act: 34 | File No.: 005-81034 | Film No.: 06713159
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017

Business Address 212-551-1600

Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G